Isojamaicin, one of the isoflavonoids from <i>Millettia griffoniana</i> Baill (Fabaceae) has anticancer effect on human prostate cancer cells
This study provides an unprecedented report of the anti-prostate cancer potential of isojamaicin and its possible underlying mechanisms. It merits further <i>in vivo</i> research to support the <i>in vitro</i> findings.
Authors
- Roland Nhouma Rebe (ORCID: https://orcid.org/0000-0003-1684-4964)
- Jordan Lembe Tonga (ORCID: https://orcid.org/0000-0002-6377-7146)
- Stéphane Zingue (ORCID: https://orcid.org/0000-0002-4854-8783)
- Dieudonné Njamen (ORCID: https://orcid.org/0000-0003-1358-8221)
- Edwin M. Mmutlane (ORCID: https://orcid.org/0000-0001-8469-916X)
- Michael Hermann Kengne Kamdem (ORCID: https://orcid.org/0000-0002-2883-3173)
- Maurice Fotsing Tagatsing
- Derek Tantoh Ndinteh (ORCID: https://orcid.org/0000-0003-4055-2304)
- Emmanuel Yankep
Institutions
- Université de Yaoundé I (CM)
- University of Johannesburg (ZA)
Publication Details
- Journal
- Journal of Complementary and Integrative Medicine
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1515/jcim-2024-0322
- Citations
- 1
- Primary Topic
- Bioactive natural compounds
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Organisation for the Prohibition of Chemical Weapons